| Aron S Adkins, MD | |
|
3802 Oakwood Mall Dr, Eau Claire, WI 54701-3016 | |
| (715) 839-9280 | |
| Not Available |
| Full Name | Aron S Adkins |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 28 Years |
| Location | 3802 Oakwood Mall Dr, Eau Claire, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336246529 | NPI | - | NPPES |
| 39718 | Other | MN | MN STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 44242 (Wisconsin) | Primary |
| 207R00000X | Internal Medicine | 44242 (Wisconsin) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Oakleaf Surgical Hospital | Altoona, WI | Hospital |
| Sacred Heart Hospital | Eau claire, WI | Hospital |
| Cumberland Memorial Hospital | Cumberland, WI | Hospital |
| Western Wisconsin Health | Baldwin, WI | Hospital |
| St Joseph's Hospital | Chippewa falls, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geiger Medical Llc | 2163719626 | 12 |
| Oakleaf Clinics Inc | 4486831328 | 81 |
News Archive
Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).
WHO is releasing new clinical protocols and guidelines to health-care workers for treating the mental health consequences of trauma and loss.
Sucampo Pharmaceuticals, Inc. and Abbott today announced that Sucampo Pharma Ltd., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc., has submitted a marketing application to the Japanese Pharmaceuticals and Medical Devices Agency for approval to market Amitiza (lubiprostone) 24 mcg for the treatment of chronic idiopathic constipation (CIC).
This prevalence study will inform the first ever Government strategy on adults with autism and Asperger's syndrome, due to be published next year.
Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to data from a meta-analysis.
› Verified 2 days ago
| Entity Name | Oakleaf Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679870315 PECOS PAC ID: 4486831328 Enrollment ID: O20110602000195 |
News Archive
Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).
WHO is releasing new clinical protocols and guidelines to health-care workers for treating the mental health consequences of trauma and loss.
Sucampo Pharmaceuticals, Inc. and Abbott today announced that Sucampo Pharma Ltd., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc., has submitted a marketing application to the Japanese Pharmaceuticals and Medical Devices Agency for approval to market Amitiza (lubiprostone) 24 mcg for the treatment of chronic idiopathic constipation (CIC).
This prevalence study will inform the first ever Government strategy on adults with autism and Asperger's syndrome, due to be published next year.
Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to data from a meta-analysis.
› Verified 2 days ago
| Entity Name | Geiger Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700234978 PECOS PAC ID: 2163719626 Enrollment ID: O20160927001350 |
News Archive
Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).
WHO is releasing new clinical protocols and guidelines to health-care workers for treating the mental health consequences of trauma and loss.
Sucampo Pharmaceuticals, Inc. and Abbott today announced that Sucampo Pharma Ltd., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc., has submitted a marketing application to the Japanese Pharmaceuticals and Medical Devices Agency for approval to market Amitiza (lubiprostone) 24 mcg for the treatment of chronic idiopathic constipation (CIC).
This prevalence study will inform the first ever Government strategy on adults with autism and Asperger's syndrome, due to be published next year.
Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to data from a meta-analysis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aron S Adkins, MD 719 W Hamilton Ave Ste B, Eau Claire, WI 54701-6970 Ph: (715) 552-9784 | Aron S Adkins, MD 3802 Oakwood Mall Dr, Eau Claire, WI 54701-3016 Ph: (715) 839-9280 |
News Archive
Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).
WHO is releasing new clinical protocols and guidelines to health-care workers for treating the mental health consequences of trauma and loss.
Sucampo Pharmaceuticals, Inc. and Abbott today announced that Sucampo Pharma Ltd., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc., has submitted a marketing application to the Japanese Pharmaceuticals and Medical Devices Agency for approval to market Amitiza (lubiprostone) 24 mcg for the treatment of chronic idiopathic constipation (CIC).
This prevalence study will inform the first ever Government strategy on adults with autism and Asperger's syndrome, due to be published next year.
Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to data from a meta-analysis.
› Verified 2 days ago
Patrick D Macken, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1425 Elderberry Ln, Eau Claire, WI 54701 Phone: 715-832-9801 | |
Sandeep K Basu, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Myles David Keroack, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2116 Craig Rd, Eau Claire, WI 54701 Phone: 715-858-4500 | |
Rebecca M Kallunki, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Dr. Sameer Ahmad Batoo, MBBS Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Ali Zaied, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Allan J Sill, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |